AstraZeneca's COVID-19 vaccine made a small contribution to earnings in the third quarter and it expects the shot to move to ‘modest profitability’ on new orders after the drugmaker posted $1.05 billion in vaccine sales https://t.co/81e6l2MO40 pic.twitter.com/QXH2nGFRaA— Reuters (@Reuters) November 12, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


